Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years--United States, June 17, 2022-May 7, 2023

Authors :: Hause, Anne M.
Marquez, Paige
Zhang, Bicheng
Moro, Pedro L.
Myers, Tanya R.
Bradley, Colin
Bazel, Samaneh
Panchanathan, Sarada S.
Shimabukuro, Tom T.
Shay, David K.
Source :: Morbidity and Mortality Weekly Report. June 9, 2023, Vol. 72 Issue 23, p621, 6 p.
Publication Year :: 2023
Abstract: As of May 7, 2023, CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all children aged 6 months--5 years receive at least 1 age-appropriate bivalent mRNA COVID-19 vaccine dose. [...]

Subjects :: United States. Food and Drug Administration -- Safety and security measures
Pfizer Inc. -- Safety and security measures
Vaccination -- Safety and security measures
Medical research -- Safety and security measures
Medicine, Experimental -- Safety and security measures
Messenger RNA -- Safety and security measures
Vaccines -- Complications and side effects
Pharmaceutical industry -- Safety and security measures
Health

Tools